1109. Valgancyclovir Dosing for Cytomegalovirus Prophylaxis in Heart Transplant Recipients

BACKGROUND: Cytomegalovirus (CMV) is one of the most common infections after transplantation and continues to cause significant morbidity and mortality. Current guidelines recommend 3-6 months of post-transplant prophylaxis with 900mg daily of valganciclovir in heart transplant recipients. At our in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Huang, Glen, Davis, Matthew R, Beaird, Omer E, Carlson, Margrit, Gaynor, Pryce, Multani, Ashrit, Deng, Mario, Nsair, Ali, Schaenman, Joanna M
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Poster Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7776552/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1295
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker